ListarArtículos (Medicina) por materia "Alirocumab"
Mostrando ítems 1-1 de 1
-
Artículo
Triglyceride concentrations and non-high-density lipoprotein cholesterol goal attainment in the ODYSSEY phase 3 trials with alirocumab
(Oxford University Press, 2020)Aims: Guidelines recommend targeting non-high-density lipoprotein cholesterol to reduce cardiovascular risk. We assessed ...